Advertisement

European Journal of Pediatrics

, Volume 148, Issue 5, pp 455–458 | Cite as

Low antithrombin III: accurate predictor of idiopathic respiratory distress syndrome in premature neonates

  • W. van den Berg
  • C. Breederveld
  • J. W. ten Cate
  • M. Peters
  • J. J. J. Borm
Neonatology

Abstract

A prospective study was performed in premature neonates to determine the predictive values of antithrombin III (AT III) deficiency immediately after birth, for the subsequent development of idiopathic respiratory distress syndrome (IRDS), intraventricular haemorrhage (IVH) and death. Of the 81 premature infants studied, 24 developed IRDS (30%). Of these 24 premature infants, 8 also developed IVH and 9 infants died within the follow-up period of 7 days. The mean plasma AT III level was significantly lower in the infants developing IRDS (0.23 U/ml vs 0.35 U/ml,P<0.0005). Within this study group 33 neonates of less than 30 weeks' gestation showed a prevalence for IRDS of 48%. In this group, AT III activity levels below 0.30 U/ml were 8.5 times as likely to result from infants with IRDS than from infants without IRDS. The diagnostic accuracy indices of criteria for the development of IRDS were: a sensitivity of 100%, a specificity of 88%, a positive predictive value of 89% and a negative predictive value of 100%. The predictive values for the development of IVH and occurrence of death were insignificant. Therefore, in premature neonates the combination of less than 30 weeks' gestation and an AT III below 0.30 U/ml is highly suggestive of IRDS and may facilitate the evaluation of early treatment.

Key words

Antithrombin III Disseminated intravascular coagulation Respiratory distress syndrome-intensive care units Neonatal 

Abbreviations

AT III

antithrombin III

DIC

disseminated intravascular coagulation

IRDS

idiopathic respiratory distress syndrome

IVH

intraventricular haemorrhage

NPV

negative predictive value

PPV

positive predictive value

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams FH, Fujiwara T, Emmamouilides G, Sandder A (1965) Surface properties and lipids from lungs of infants with hyaline membrane disease. J Pediatr 61:357–364Google Scholar
  2. 2.
    Altstatt LB, Dennis LH, Sundell H, Malan A, Harrison V, Hedvall G, Eickelberger J, Fogel B, Stahlman M (1971) Disseminated intravascular coagulation and hyaline membrane disease. Biol Neonate 19:227–240Google Scholar
  3. 3.
    Ambrus CM, Weintraub DH, Dunphy D, Dowd JE, Pickren JW, Niswander KR, Ambrus JL (1963) Studies on hyaline membrane disease. I. The fibronolysin system in pathogenesis and therapy. Pediatrics 32:10–24Google Scholar
  4. 4.
    Avery ME, Mead J (1959) Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97:517–523Google Scholar
  5. 5.
    Beverley DW, Chance GW, Inwood MJ, Schaus M, O'Keefe B (1984) Intraventricular haemorrhage and haemostasis defects. Arch Dis Child 54:444–448Google Scholar
  6. 6.
    Chessels JM, Wigglesworth JS (1972) Coagulation studies in preterm infants with respiratory distress and intracranial haemorrhage. Arch Dis Child 47:564–570Google Scholar
  7. 7.
    Cohen MM, Weintraub DH, Lilienfeld AM (1960) The relationship of pulmonary hyaline membrane to certain factors on pregnancy and delivery. Pediatrics 2:42–50Google Scholar
  8. 8.
    Gilles FH, Price RA, Kevy SV, Berenberg W (1971) Fibrinolytic activity in the ganglionic eminence of the premature human brain. Biol Neonate 426–432Google Scholar
  9. 9.
    Hathaway W (1975) The bleeding newborn. Semin Hematol 12: 175–188Google Scholar
  10. 10.
    Hathaway WE, Neumann LL, Borden CA, Jacobsen LJ (1978) Immunologic studies of antithrombin III heparin cofactor in the newborn. Thromb Haemost 39:624–630Google Scholar
  11. 11.
    Kahlé LH, Schipper HG, Jenkins CSP, Cate JW ten (1978) Antithrombin III. I. Evaluation of an automated antithrombin III method. Thromb Res 12:1003–1014Google Scholar
  12. 12.
    Kloosterman GJ, Huidekoper BL (1970) On intra-uterine growth. The significance of prenatal care. Int J Gynaecol Obstetr 8:895–912Google Scholar
  13. 13.
    Mahansandana CH, Hathaway WE (1973) Circulating anticoagulants in the newborn: relation to hypercoagulativity and the idiopathic respiratory distress syndrome. Pediatr Res 7:670–673Google Scholar
  14. 14.
    Markarian M, Githens JH, Rozenblüt E, Fernandez F, Jackson JJ, Bannon AE, Lindley A, Lubchenko LO, Martorell R (1970) Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and haemorrhage I. Coagulation studies. Biol Neonate 17:84–97Google Scholar
  15. 15.
    McDonald MM, Johnson ML, Rumack CM, Koops BL, Guggenheim MA, Babb C, Hathaway WE (1984) Role of coagulopathy in newborn intracranial haemorrhage. Pediatrics 74:26–31Google Scholar
  16. 16.
    Merritt TA, Hallman M, Bloom BT, Bery C, Benirschke K, Salm D, Key T, Edwards D, Jarven Paa AL, Pohjavnori M, Kan Kaan Paa K, Kunnas M, Paatero H, Rapda J, Jaaskelainen J (1986) Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 13:785–790Google Scholar
  17. 17.
    Neumann LL, Hathaway WE, Clarke S, Porden C (1974) Antithrombin III levels in term and preterm newborn infants. Clin Res 22:226AGoogle Scholar
  18. 18.
    Papile LA, Burstein J, Burstein R, Koffler H (1978) Incidence and evolution of subependymal and intraventricular haemorrhage: a study of infants with birth weights less than 1500 gr. J Pediatr 92:529–534Google Scholar
  19. 19.
    Perlman JM, McMenamin JB, Volpe JJ (1983) Fluctuating cerebral bloodflow velocity in respiratory distress syndrome. N Engl J Med 309:204–209Google Scholar
  20. 20.
    Peters M, Cate JW ten, Breederveld C, Leeuw R de, Emeis JJ, Koppe JG (1984) Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: poor prognosis. Pediatr Res 18:273–276Google Scholar
  21. 21.
    Sackett DL, Haynes RB, Tugwell P (eds) (1985) Clinical epidemiology, a basic science for clinical medicine, 1st edn. Little, Brown, & Co, Boston, pp 59–138Google Scholar
  22. 22.
    Silverman WA, Silverman RH (1958) Incidence of hyaline membrane in premature infants. Lancet II:588Google Scholar
  23. 23.
    Stahlman M (1970) The relation of disseminated intravscular coagulation to hyaline membrane disease. Biol Neonate 16:177–188Google Scholar
  24. 24.
    Stark CR, Abramson D, Erkan V (1984) Intravascular coagulation and hyaline membrane disease of the newborn. Lancet II: 1180–1181Google Scholar
  25. 25.
    Turner T, Prowse CV, Prescott PJ, Cash J (1981) A clinical trial on the early detection and correction of haemostatic defects in selected high-risk neonates. Br J Haematol 47:65–75Google Scholar
  26. 26.
    Watkins MN, Swan S, Capnini JA, Gardner TH, Zuckerman L, Vagher JP (1980) Coagulation changes in the newborn with respiratory failure. Thromb Res 17:153–175Google Scholar
  27. 27.
    Weissbach G, Domula M, Lenk H, Schneider P (1974) The progressive antithrombin activity and its relations to other factors of the coagulation system in newborns. Acta Paediatr Scand 67:555–561Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • W. van den Berg
    • 1
  • C. Breederveld
    • 1
    • 2
  • J. W. ten Cate
    • 1
  • M. Peters
    • 2
  • J. J. J. Borm
    • 1
  1. 1.Division of Haemostasis and ThrombosisAcademic Medical Centre, University of AmsterdamAmsterdamThe Netherlands
  2. 2.Department of PaediatricsAcademic Medical Centre, University of AmsterdamAmsterdamThe Netherlands

Personalised recommendations